Cargando…
Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines.
Expression of Bcl-2 is life-sustaining for small-cell lung cancer cells and associated with drug resistance. In the present study, the interactions between the bcl-2 antisense oligodeoxynucleotide 2009 and the chemotherapeutic agents etoposide, doxorubicin and cisplatin were investigated on small-ce...
Autores principales: | Zangemeister-Wittke, U., Schenker, T., Luedke, G. H., Stahel, R. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063150/ https://www.ncbi.nlm.nih.gov/pubmed/9792147 |
Ejemplares similares
-
Panobinostat Synergistically Enhances the Cytotoxic Effects of Cisplatin, Doxorubicin or Etoposide on High-Risk Neuroblastoma Cells
por: Wang, Guan, et al.
Publicado: (2013) -
Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
por: Zangemeister-Wittke, U., et al.
Publicado: (1994) -
Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines
por: Mahbub, AA, et al.
Publicado: (2015) -
Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines
por: Mahbub, A A, et al.
Publicado: (2015) -
Effect of cisplatin and c-myb antisense phosphorothioate oligodeoxynucleotides combination on a human colon carcinoma cell line in vitro and in vivo.
por: Del Bufalo, D., et al.
Publicado: (1996)